You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 16, April 22, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Thrombolysis
 •Neurology
 •Cerebrovascular Disease
 •Cardiovascular System
 •Arrhythmias
 •Cardiovascular Intervention
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Patients With Nonvalvular Atrial Fibrillation at Low Risk of Stroke During Treatment With Aspirin

Stroke Prevention in Atrial Fibrillation III Study

The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators

JAMA. 1998;279:1273-1277.

Context.— Nonvalvular atrial fibrillation (AF) carries an increased risk for stroke, but absolute rates of stroke vary widely within the broad spectrum of AF patients.

Objective.— To prospectively validate a risk stratification scheme identifying patients with AF with low rates of stroke when given aspirin.

Design.— Prospective cohort study with mean duration of follow-up of 2.0 years, conducted between 1993 and 1997.

Setting.— Outpatient clinics affiliated with academic medical centers.

Patients.— Patients with AF categorized as "low risk" based on the absence of 4 prespecified thromboembolic risk factors: recent congestive heart failure or left ventricular fractional shortening of 25% or less, previous thromboembolism, systolic blood pressure greater than 160 mm Hg, or female sex at age older than 75 years.

Intervention.— All participants given aspirin, 325 mg/d.

Main Outcome Measures.— Ischemic stroke (considered disabling when Rankin score was II or worse 1-3 months later) and systemic embolism (primary events).

Results.— Among 892 participants, the mean (SD) age was 67 (10) years, 78% were men, and histories of hypertension, diabetes, and ischemic heart disease were present in 46%, 13%, and 16%, respectively. The rate of primary events was 2.2% per year (95% confidence interval [CI], 1.6%-3.0%), of ischemic stroke was 2.0% per year (95% CI, 1.5%-2.8%), and of disabling ischemic strokes was 0.8% per year (95% CI, 0.5%-1.3%). Those with a history of hypertension had a higher rate of primary events (3.6% per year) than those with no history of hypertension (1.1% per year) (P<.001). The rate of disabling ischemic stroke was low in those with and without a history of hypertension (1.4% per year and 0.5% per year, respectively). The rate of major bleeding during aspirin therapy was 0.5% per year.

Conclusion.— Patients with AF who have relatively low rates of ischemic stroke, particularly disabling stroke, during treatment with aspirin can be reliably identified.




Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTER

Patients With Atrial Fibrillation at Low Risk of Stroke
Raymond Cheung, Daniel E. Singer, Ruth McBride, Robert G. Hart, and Jonathan L. Halperin
JAMA. 1998;280(10):882-883.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Stroke Treatment: Promising but Still Struggling
Louis R. Caplan
JAMA. 1998;279(16):1304-1306.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies
Crandall et al.
Mayo Clin Proc. 2009;84:643-662.
ABSTRACT | FULL TEXT  

Use of Ordinal Outcomes in Vascular Prevention Trials: Comparison With Binary Outcomes in Published Trials * Supplemental Appendix I: Statistical Tests Compared * Supplemental Appendix II: Supplementary Analyses * Supplemental Appendix III: Results
Bath et al.
Stroke 2008;39:2817-2823.
ABSTRACT | FULL TEXT  

Prevention of stroke in patients with atrial fibrillation: current strategies and future directions
Hohnloser et al.
Eur Heart J Suppl 2008;10:H4-H10.
ABSTRACT | FULL TEXT  

Antiplatelet Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Patrono et al.
Chest 2008;133:199S-233S.
ABSTRACT | FULL TEXT  

Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation
Stroke Risk in Atrial Fibrillation Working Group
Stroke 2008;39:1901-1910.
ABSTRACT | FULL TEXT  

Stroke and Its Prevention in Chronic Kidney Disease
Khella and Bleicher
CJASN 2007;2:1343-1351.
ABSTRACT | FULL TEXT  

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
Hart et al.
ANN INTERN MED 2007;146:857-867.
ABSTRACT | FULL TEXT  

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:651-745.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:854-906.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:e149-e246.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:e257-e354.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:700-752.
FULL TEXT  

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Authors/Task Force Members et al.
Eur Heart J 2006;27:1979-2030.
FULL TEXT  

Stroke prophylaxis in atrial fibrillation: who gets it and who does not?: Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)
Friberg et al.
Eur Heart J 2006;27:1954-1964.
ABSTRACT | FULL TEXT  

Relationship of Atrial Fibrillation and Stroke After Coronary Artery Bypass Graft Surgery: When is Anticoagulation Indicated?
Kollar et al.
Ann. Thorac. Surg. 2006;82:515-523.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
Chan et al.
J Am Coll Cardiol 2006;47:2513-2520.
ABSTRACT | FULL TEXT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Circulation 2006;113:e873-e923.
ABSTRACT | FULL TEXT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Stroke 2006;37:1583-1633.
ABSTRACT | FULL TEXT  

Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate Anticoagulation
Waldo et al.
J Am Coll Cardiol 2005;46:1729-1736.
ABSTRACT | FULL TEXT  

Are Transthoracic Echocardiographic Parameters Associated With Atrial Fibrillation Recurrence or Stroke?: Results From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
Olshansky et al.
J Am Coll Cardiol 2005;45:2026-2033.
ABSTRACT | FULL TEXT  

The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors
Gersh et al.
Eur Heart J Suppl 2005;7:C5-C11.
ABSTRACT | FULL TEXT  

Current status of stroke prevention in patients with atrial fibrillation
Bath et al.
Eur Heart J Suppl 2005;7:C12-C18.
ABSTRACT | FULL TEXT  

Emerging therapies for stroke prevention in atrial fibrillation
O'Donnell et al.
Eur Heart J Suppl 2005;7:C19-C27.
ABSTRACT | FULL TEXT  

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: A randomized multicenter study
Perez-Gomez et al.
J Am Coll Cardiol 2004;44:1557-1566.
ABSTRACT | FULL TEXT  

Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin
Gage et al.
Circulation 2004;110:2287-2292.
ABSTRACT | FULL TEXT  

Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry
Steger et al.
Eur Heart J 2004;25:1734-1740.
ABSTRACT | FULL TEXT  

Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Patrono et al.
Chest 2004;126:234S-264S.
ABSTRACT | FULL TEXT  

Relationship of interleukin-6 and C-Reactive protein to the prothrombotic state in chronic atrial fibrillation
Conway et al.
J Am Coll Cardiol 2004;43:2075-2082.
ABSTRACT | FULL TEXT  

A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community: The Framingham Heart Study
Wang et al.
JAMA 2003;290:1049-1056.
ABSTRACT | FULL TEXT  

New strategies in the surgical treatment of atrial fibrillation
Sie et al.
Cardiovasc Res 2003;58:501-509.
ABSTRACT | FULL TEXT  

Lessons from the Stroke Prevention in Atrial Fibrillation Trials
Hart et al.
ANN INTERN MED 2003;138:831-838.
ABSTRACT | FULL TEXT  

Warfarin for non-valvar atrial fibrillation: still underused in the 21st century?
Bo et al.
Heart 2003;89:553-554.
FULL TEXT  

A Clinical Prediction Rule to Identify Patients With Atrial Fibrillation and a Low Risk for Stroke While Taking Aspirin
van Walraven et al.
Arch Intern Med 2003;163:936-943.
ABSTRACT | FULL TEXT  

Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
Rutten et al.
Fam Pract 2003;20:16-21.
ABSTRACT | FULL TEXT  

Atrial fibrillation and heart failure: natural history and pharmacological treatment
Savelieva and John Camm
Europace 2003;5:S5-S19.
ABSTRACT | FULL TEXT  

Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation: An Individual Patient Meta-analysis
van Walraven et al.
JAMA 2002;288:2441-2448.
ABSTRACT | FULL TEXT  

New insights into the mechanisms and management of atrial fibrillation
Khairy and Nattel
CMAJ 2002;167:1012-1020.
ABSTRACT | FULL TEXT  

An assessment of guidelines for prevention of ischemic stroke
Hart and Bailey
Neurology 2002;59:977-982.
ABSTRACT | FULL TEXT  

Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors
Conway et al.
Circulation 2002;106:1962-1967.
ABSTRACT | FULL TEXT  

Occurrence of Hemispheric and Retinal Ischemia in Atrial Fibrillation Compared With Carotid Stenosis * Editorial Comment
Anderson et al.
Stroke 2002;33:1963-1968.
ABSTRACT | FULL TEXT  

Management of the Older Person With Atrial Fibrillation
Aronow
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002;57:M352-363.
ABSTRACT | FULL TEXT  

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
Circulation 2001;104:2118-2150.
FULL TEXT  

Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur Heart J 2001;22:1852-1923.
 

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
J Am Coll Cardiol 2001;38:1266-1266.
FULL TEXT  

Long term anticoagulation or antiplatelet treatment
Cleland et al.
BMJ 2001;323:233-233.
FULL TEXT  

Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage et al.
JAMA 2001;285:2864-2870.
ABSTRACT | FULL TEXT  

New-Onset Atrial Fibrillation : Sex Differences in Presentation, Treatment, and Outcome
Humphries et al.
Circulation 2001;103:2365-2370.
ABSTRACT | FULL TEXT  

Atrial Fibrillation
Falk
NEJM 2001;344:1067-1078.
FULL TEXT  

Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation
Klein et al.
J Am Coll Cardiol 2001;37:691-704.
ABSTRACT | FULL TEXT  

Atrial Fibrillation and Stroke : Concepts and Controversies
Hart and Halperin
Stroke 2001;32:803-808.
FULL TEXT  

Epidemiology and natural history of atrial fibrillation: clinical implications
Chugh et al.
J Am Coll Cardiol 2001;37:371-378.
ABSTRACT | FULL TEXT  

Platelet-Active Drugs : The Relationships Among Dose, Effectiveness, and Side Effects
Patrono et al.
Chest 2001;119:39S-63S.
FULL TEXT  

Antithrombotic Therapy in Atrial Fibrillation
Albers et al.
Chest 2001;119:194S-206S.
FULL TEXT  

Geriatric Assessment and Anticoagulation in Elderly Patients With Chronic Atrial Fibrillation
Bellelli et al.
Arch Intern Med 2000;160:2402-2403.
FULL TEXT  

Implications of Stroke Risk Criteria on the Anticoagulation Decision in Nonvalvular Atrial Fibrillation : The Anticoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Go et al.
Circulation 2000;102:11-13.
ABSTRACT | FULL TEXT  

Anticoagulation for Chronic Atrial Fibrillation
Stern et al.
JAMA 2000;283:2901-2903.
FULL TEXT  

Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
Hart and Pearce
ANN INTERN MED 2000;132:841-842.
FULL TEXT  

The Quality of Anticoagulation Management
Ansell
Arch Intern Med 2000;160:895-896.
FULL TEXT  

Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
Hart et al.
J Am Coll Cardiol 2000;35:183-187.
ABSTRACT | FULL TEXT  

Reviews: Atrial Fibrillation: Current and Future Strategies for Management
Burkart and Curtis
J CARDIOVASC PHARMACOL THER 2000;5:151-160.
 

Markers of Thrombin and Platelet Activity in Patients With Atrial Fibrillation : Correlation With Stroke Among 1531 Participants in the Stroke Prevention in Atrial Fibrillation III Study
Feinberg et al.
Stroke 1999;30:2547-2553.
ABSTRACT | FULL TEXT  

Warfarin in atrial fibrillation: underused in the elderly, often inappropriately used in the young
HART
Heart 1999;82:539-540.
FULL TEXT  

Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand?
Deplanque et al.
Heart 1999;82:563-569.
ABSTRACT | FULL TEXT  

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin
Hellemons et al.
BMJ 1999;319:958-964.
ABSTRACT | FULL TEXT  

A Patient Decision Aid Regarding Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation: A Randomized Controlled Trial
Man-Son-Hing et al.
JAMA 1999;282:737-743.
ABSTRACT | FULL TEXT  

Evidence based cardiology: Prevention of ischaemic stroke
Barnett et al.
BMJ 1999;318:1539-1543.
FULL TEXT  

Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation : Analysis of 2012 Participants in the SPAF I–III Clinical Trials
Hart et al.
Stroke 1999;30:1223-1229.
ABSTRACT | FULL TEXT  

Lone Atrial Fibrillation in Elderly Persons: A Marker for Cardiovascular Risk
Kopecky et al.
Arch Intern Med 1999;159:1118-1122.
ABSTRACT | FULL TEXT  

Preventing Stroke in Patients With Atrial Fibrillation
Ezekowitz and Levine
JAMA 1999;281:1830-1835.
ABSTRACT | FULL TEXT  

Warfarin vs Aspirin and AFASAK 2
Bloom et al.
Arch Intern Med 1999;159:1010-1011.
FULL TEXT  

Aortic Plaque in Atrial Fibrillation : Prevalence, Predictors, and Thromboembolic Implications
Blackshear et al.
Stroke 1999;30:834-840.
ABSTRACT | FULL TEXT  

Patients With Atrial Fibrillation at Low Risk of Stroke
Cheung et al.
JAMA 1998;280:882-883.
FULL TEXT  

Choice of Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation: Warfarin, Aspirin, or Both?
Albers
Arch Intern Med 1998;158:1487-1491.
FULL TEXT  

AF and Stroke II: When Is Aspirin Enough?
JWatch Emergency Med. 1998;1998:9-9.
FULL TEXT  

Identifying AF Patients at Low Risk for Stroke
Journal Watch Cardiology 1998;1998:1-1.
FULL TEXT  

Aspirin Reasonable for Low-Risk Atrial Fibrillation Patients
JWatch General 1998;1998:2-2.
FULL TEXT  

Stroke Treatment: Promising but Still Struggling
Caplan
JAMA 1998;279:1304-1306.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.